BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 28, 2014
View Archived Issues
Researchers present novel radiomitigating compounds
Read More
Nuvilex forms consortium to oversee development of treatment for type 1 diabetes
Read More
Janssen and Transposagen to collaborate on allogeneic CAR T-cell therapies
Read More
Thermo Fisher Scientific and Samsung Electronics initiate POC diagnostic collaboration
Read More
Santhera and PPMD collaborate on risk/benefit analysis of idebenone as DMD respiratory therapy
Read More
Sevion enters into chimerasome research agreement with Avidity NanoMedicines
Read More
ACC inhibitors reported in Nimbus Discovery patent
Read More
First in vitro and in vivo data for DNA-PK and mTOR kinase dual inhibitor CC-115
Read More
Human tolerability and new preclinical data presented for ShK-186
Read More
PEGylated H-NOX protein may enhance radiotherapy for glioblastoma
Read More
Recombinant human placental growth factor as promising therapy for artherosclerosis
Read More
Project targeting CD73 supported by AmorChem and Univalor
Read More
Phase I results presented for AZD-7451 in adults with recurrent glioblastoma multiforme
Read More
Tonix Pharmaceuticals initiates ascending-dose phase I trial of oral TNX-201
Read More
FDA accepts for review Dysport sBLA for upper limb spasticity
Read More
Lilly patent describes prostanoid EP4 receptor antagonists
Read More
EZH2 inhibitors prepared and tested at GlaxoSmithKline
Read More
Novartis starts recruitment of patients with Sjogren's syndrome for phase II trial of CFZ-533
Read More
Takeda synthesizes PKC theta inhibitors
Read More
Chinese team divulges HGFR/VEGFR inhibitors for cancer
Read More
Kyowa Hakko Kirin to launch pegfilgrastim in Japan
Read More
Novartis applies for approval of vildagliptin/metformin combination tablets in Japan
Read More
First-in-human data for the anti-IL-13 antibody RPC-4046
Read More